Detalhe da pesquisa
1.
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.
Br J Cancer
; 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38600325
2.
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer.
J Pathol
; 260(5): 621-636, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37587096
3.
Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers.
J Pathol
; 258(1): 1-3, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35647895
4.
Translational genomics of ovarian clear cell carcinoma.
Semin Cancer Biol
; 61: 121-131, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31698086
5.
Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.
J Pathol
; 250(3): 262-274, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31755096
6.
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI).
Int J Gynecol Cancer
; 31(11): 1471-1475, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34518240
7.
Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Breast Cancer Res
; 22(1): 74, 2020 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32641077
8.
Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.
Genome Res
; 24(11): 1854-68, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25122612
9.
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
J Pathol
; 240(3): 315-328, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27512948
10.
Comparative proteomic assessment of matrisome enrichment methodologies.
Biochem J
; 473(21): 3979-3995, 2016 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27589945
11.
Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis.
PLoS Med
; 13(2): e1001961, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26881778
12.
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.
EMBO J
; 31(5): 1160-76, 2012 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-22293751
13.
Breast cancer heterogeneity: parallel evolution or conscious uncoupling?
J Pathol
; 237(1): 1-3, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25953517
14.
SF3B1 mutations constitute a novel therapeutic target in breast cancer.
J Pathol
; 235(4): 571-80, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25424858
15.
Genomic landscape of adenoid cystic carcinoma of the breast.
J Pathol
; 237(2): 179-89, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26095796
16.
An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer.
Breast Cancer Res
; 17(1): 131, 2015 Sep 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26395345
17.
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. .
Mod Pathol
; 28(3): 340-51, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25412848
18.
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
J Pathol
; 232(5): 553-65, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24395524
19.
Complex landscapes of somatic rearrangement in human breast cancer genomes.
Nature
; 462(7276): 1005-10, 2009 Dec 24.
Artigo
Inglês
| MEDLINE | ID: mdl-20033038
20.
Resistance to therapy caused by intragenic deletion in BRCA2.
Nature
; 451(7182): 1111-5, 2008 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-18264088